Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease
Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal. Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills…Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression
Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is a common neuropsychiatric feature of Parkinson’s…Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy
Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…Characterising Natural Killer cells in early Parkinson’s disease
Objective: To determine whether the number and phenotype of Natural Killer (NK) cells in the blood is altered in early Parkinson’s disease (PD). Background: Accumulating…Intermediate cardiac denervation in early Parkinson’s disease
Objective: This study is aimed to evaluate the longitudinal associations between cardiac sympathetic denervation and cognitive status in Parkinson’s disease (PD). Background: There lacks an…Multi-modal prognostic biomarkers for Parkinson’s disease progression and severity
Objective: To determine a pathophysiological panel of biomarkers significantly associated with the severity and the disease progression of Parkinson’s disease. Background: Detecting, monitoring and predicting…The USP Project: Understanding the Scope and Value of Parkinson’s Specialist Nursing
Objective: This paper will present evidence from the first stakeholder-driven UK study to explore in-depth the role and value of the Parkinson’s Nurse Specialist (PNS)…Association between dihydropyridines and dementia conversion in Parkinson’s disease
Objective: To investigate the role of antihypertensive drugs, including dihydropyridines, on nigrostriatal dopamine and dementia conversion in Parkinson's disease Background: Several experimental and clinical studies…Evaluation of the anxiolytic effects of naringenin in rotenone-induced rat model of Parkinson’s disease by an elevated plus maze test
Objective: The study was designed to assess the anxiolytic effects of naringenin on rotenone-induced anxiety-like behavior, biochemical and neurochemical alterations. Background: Anxiety is a preclinical…Long-term dietary and supplemental intake of folate, vitamin B6 and vitamin B12 and the incidence of Parkinson’s disease in a sample of US women and men
Objective: To examine the association of long-term dietary and supplemental intake of folate, vitamin B6 and vitamin B12 with the incidence of Parkinson’s disease (PD)…
- « Previous Page
- 1
- …
- 226
- 227
- 228
- 229
- 230
- …
- 338
- Next Page »